The Valley Desk

NCT02614794 · Interventional trial

A Study of Tucatinib vs. Placebo in Combination With Capecitabine & Trastuzumab in Patients With Advanced HER2+ Breast Cancer

Overall registry status Completed

Phase 2

Conditions HER2 Positive Breast Cancer

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov